Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer

PURPOSES: The purposes of this study were to investigate the incidence of lymphedema in patients with breast cancer during and after adjuvant treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC), to identify predictors for development of lymphedema, and to describe consequences in daily...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Support Care Cancer
Main Authors: Hidding, Janine T., Beurskens, Carien H. G., van der Wees, Philip J., Bos, Wilmy C. A. M., Nijhuis-van der Sanden, Maria W. G., van Laarhoven, Hanneke W. M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5876252/
https://ncbi.nlm.nih.gov/pubmed/29127528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3907-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados